Degenerative Disc Disease clinical trials at UCSF

1 research study open to eligible people

Degenerative disc disease is the breakdown of spinal discs that causes pain and stiffness. UCSF is testing a cell-based injection plus hyaluronic acid for chronic low back pain. UCSF is collecting data on safety and pain outcomes.

Showing trials for

  • Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

    open to eligible people ages 18 years and up

    The primary purpose of this study is to evaluate the efficacy of rexlemestrocel-L+HA compared to control in reducing low back pain at 12 months post-treatment and safety of a single injection of rexlemestrocel-L+HA injected into a lumbar intervertebral disc compared to control through 12 months post-treatment.

    San Francisco, California and other locations

Last updated: